EUVIMEDEUVIMED entdecken
Crossref

FAS/FAS-ligand Apoptotic Complex Deregulation in Laryngeal Squamous Cell Carcinomas

Michail Athanasopoulos, Vasileios Papanikolaou, Dimitrios Roukas, Aristeidis Chrysovergis, Georgios Papanastasiou, Maria Adamopoulou, Ioanna E Metaxas, Evangelos Tsiambas, Georgios Tsouvelas, Nicholas Mastronikolis, Eythimios Kyrodimos, Nikolaos Kavantzas und 1 weitere

Anticancer Research · 2026

DOI: 10.21873/anticanres.18038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Michail Athanasopoulos und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, University General Hospital of Patras, Patras, Greece; miathanasopoulos@gmail.com. Hauptthemen laut MEDLINE: Fas Ligand Protein, Carcinoma, Squamous Cell, fas Receptor, Apoptosis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: FAS/FAS-ligand (FAS-L) complex is implicated in critical cell functions including programmed cell death (apoptosis) and immune response regulation. FAS and FAS-ligand are members of the tumor necrosis factor (TNF) superfamily. Their activation triggers the caspase-mediated apoptotic cataract. The aim of this study was to investigate the role of their altered co-expression in a series of laryngeal squamous cell carcinomas (LSCCs). MATERIALS AND METHODS: A set of fifty (n=50) LSCC archival tissue sections was analyzed by performing a combination of immunohistochemistry (IHC) and digital image analysis (DIA) assays for determining the expression of FAS/FAS-L expression. RESULTS: A broad spectrum of FAS/FAS-L expression values were detected across the examined cases. A significant negative correlation was found between FAS and FAS-L overall expression (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fas Ligand ProteinCarcinoma, Squamous Cellfas ReceptorApoptosisLaryngeal NeoplasmsHumansFemaleMaleMiddle AgedImmunohistochemistryAgedNeoplasm Staging

Stichwörter der Autor:innen

FASFASLapoptosiscarcinomaimmunohistochemistryprotein

Substanzen

Fas Ligand Proteinfas ReceptorFAS protein, humanFASLG protein, human

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, University General Hospital of Patras, Patras, Greece; miathanasopoulos@gmail.com.
  • Department of Otolaryngology, ''Sotiria'' Hospital, Athens, Greece.
  • Department of Cytology, 417 Veterans Army Hospital (NIMTS), Athens, Greece.
  • Department of Otolaryngology ''Elpis'' Hospital, Athens, Greece.
  • Department of Maxillofacial Surgery, Medical School, University of Ioannina, Ioannina, Greece.
  • School of Science and Technology, Department of Science and Mathematics, Biomedical Sciences, Deree-The American College of Greece, Athens, Greece.

Zitieren

APA

Athanasopoulos, M., Papanikolaou, V., Roukas, D., Chrysovergis, A., Papanastasiou, G., Adamopoulou, M., Metaxas, I. E., Tsiambas, E., Tsouvelas, G., Mastronikolis, N., Kyrodimos, E., Kavantzas, N., & Agrogiannis, G. (2026). FAS/FAS-ligand Apoptotic Complex Deregulation in Laryngeal Squamous Cell Carcinomas. Anticancer Research. https://doi.org/10.21873/anticanres.18038

Vancouver

Athanasopoulos M, Papanikolaou V, Roukas D, Chrysovergis A, Papanastasiou G, Adamopoulou M, et al. FAS/FAS-ligand Apoptotic Complex Deregulation in Laryngeal Squamous Cell Carcinomas. Anticancer Research. 2026. doi:10.21873/anticanres.18038

BibTeX
@article{Athanasopoulos2026,
  author = {Athanasopoulos, Michail and Papanikolaou, Vasileios and Roukas, Dimitrios and Chrysovergis, Aristeidis and Papanastasiou, Georgios and Adamopoulou, Maria and Metaxas, Ioanna E and Tsiambas, Evangelos and Tsouvelas, Georgios and Mastronikolis, Nicholas and Kyrodimos, Eythimios and Kavantzas, Nikolaos and Agrogiannis, Georgios},
  title = {FAS/FAS-ligand Apoptotic Complex Deregulation in Laryngeal Squamous Cell Carcinomas},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.18038}
}
Kostenlos starten →